Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,024 USD | -1.97% |
|
-2.55% | +16.60% |
07-03 | Regeneron, Sanofi Say Chronic Obstructive Pulmonary Disease Treatment Gains European Approval | MT |
07-03 | Sanofi obtains EU approval for Dupixent | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.60% | 110B | |
+15.58% | 121B | |
+18.20% | 25.98B | |
-24.33% | 19.27B | |
-18.40% | 15.99B | |
-17.95% | 15.66B | |
-48.32% | 14.5B | |
+58.78% | 14.47B | |
+4.91% | 13.91B | |
+100.06% | 10B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Regeneron Pharmaceuticals Insider Sold Shares Worth $1,190,564, According to a Recent SEC Filing